FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3045447168> ?p ?o ?g. }

• W3045447168 endingPage "595" @default.
• W3045447168 startingPage "583" @default.
• W3045447168 abstract "Prior to the approval of sorafenib, hepatic arterial infusion chemotherapy (HAIC) was offered to patients with advanced hepatocellular carcinoma (HCC) in East Asia, particularly Japan. According to the Japanese guidelines, HAIC is recommended as one of the treatment options in patients without extrahepatic metastasis (EHM).The present cohort study compared the use of HAIC and sorafenib on outcomes of patients with advanced HCC. Consecutive patients with advanced HCC who received HAIC or sorafenib as a first-line systemic therapy were enrolled from 10 Japanese institutions. The primary outcomes were overall survival (OS) in patients with macrovascular invasion (MVI), but without EHM, and OS in patients without both MVI and EHM.Between 2009 and 2016, 2,006 patients were enrolled (541 HAIC patients, 1,465 sorafenib patients). After propensity score matching, the OS of patients with MVI but without EHM was significantly longer in the HAIC group compared with the sorafenib group (10.1 vs. 9.1 months for the HAIC and sorafenib groups, respectively; n = 170 for each group; hazard ratio [HR] 0.668; 95% confidence interval [95% CI] 0.475-0.935; p = 0.018). There was no significant difference in OS between patients without both MVI and EHM (12.2 vs. 15.4 months for the HAIC and sorafenib groups, respectively; n = 76 in each cohort after propensity score matching; HR 1.227; 95% CI 0.699-2.155; p = 0.475).HAIC is a potential front-line treatment choice in a subpopulation of patients with advanced HCC with MVI but without EHM." @default.
• W3045447168 created "2020-07-29" @default.
• W3045447168 creator A5010887566 @default.
• W3045447168 creator A5022537134 @default.
• W3045447168 creator A5023958825 @default.
• W3045447168 creator A5024065548 @default.
• W3045447168 creator A5026733873 @default.
• W3045447168 creator A5030718094 @default.
• W3045447168 creator A5030763210 @default.
• W3045447168 creator A5032900701 @default.
• W3045447168 creator A5034244372 @default.
• W3045447168 creator A5037963685 @default.
• W3045447168 creator A5041139736 @default.
• W3045447168 creator A5044342382 @default.
• W3045447168 creator A5052001303 @default.
• W3045447168 creator A5058321251 @default.
• W3045447168 creator A5064872583 @default.
• W3045447168 creator A5066924600 @default.
• W3045447168 creator A5069065380 @default.
• W3045447168 creator A5073056054 @default.
• W3045447168 creator A5074112363 @default.
• W3045447168 creator A5076725199 @default.
• W3045447168 creator A5085351803 @default.
• W3045447168 creator A5086023651 @default.
• W3045447168 date "2020-01-01" @default.
• W3045447168 modified "2023-10-12" @default.
• W3045447168 title "Hepatic Arterial Infusion Chemotherapy versus Sorafenib in Patients with Advanced Hepatocellular Carcinoma" @default.
• W3045447168 cites W1511734497 @default.
• W3045447168 cites W1967541992 @default.
• W3045447168 cites W1970100282 @default.
• W3045447168 cites W1971837077 @default.
• W3045447168 cites W1994193851 @default.
• W3045447168 cites W1995418633 @default.
• W3045447168 cites W2000610516 @default.
• W3045447168 cites W2013804937 @default.
• W3045447168 cites W2022340378 @default.
• W3045447168 cites W2032084645 @default.
• W3045447168 cites W2090520513 @default.
• W3045447168 cites W2096797256 @default.
• W3045447168 cites W2512061943 @default.
• W3045447168 cites W2558253459 @default.
• W3045447168 cites W2591717879 @default.
• W3045447168 cites W2745488932 @default.
• W3045447168 cites W2760867461 @default.
• W3045447168 cites W2765678441 @default.
• W3045447168 cites W2773914067 @default.
• W3045447168 cites W2787358630 @default.
• W3045447168 cites W2789635905 @default.
• W3045447168 cites W2795708663 @default.
• W3045447168 cites W2839856130 @default.
• W3045447168 cites W2905923080 @default.
• W3045447168 cites W2916339743 @default.
• W3045447168 cites W2917837889 @default.
• W3045447168 cites W2944033593 @default.
• W3045447168 cites W2990862758 @default.
• W3045447168 cites W3021228866 @default.
• W3045447168 cites W4211183069 @default.
• W3045447168 doi "https://doi.org/10.1159/000508724" @default.
• W3045447168 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7548914" @default.
• W3045447168 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33083282" @default.
• W3045447168 hasPublicationYear "2020" @default.
• W3045447168 type Work @default.
• W3045447168 sameAs 3045447168 @default.
• W3045447168 citedByCount "57" @default.
• W3045447168 countsByYear W30454471682021 @default.
• W3045447168 countsByYear W30454471682022 @default.
• W3045447168 countsByYear W30454471682023 @default.
• W3045447168 crossrefType "journal-article" @default.
• W3045447168 hasAuthorship W3045447168A5010887566 @default.
• W3045447168 hasAuthorship W3045447168A5022537134 @default.
• W3045447168 hasAuthorship W3045447168A5023958825 @default.
• W3045447168 hasAuthorship W3045447168A5024065548 @default.
• W3045447168 hasAuthorship W3045447168A5026733873 @default.
• W3045447168 hasAuthorship W3045447168A5030718094 @default.
• W3045447168 hasAuthorship W3045447168A5030763210 @default.
• W3045447168 hasAuthorship W3045447168A5032900701 @default.
• W3045447168 hasAuthorship W3045447168A5034244372 @default.
• W3045447168 hasAuthorship W3045447168A5037963685 @default.
• W3045447168 hasAuthorship W3045447168A5041139736 @default.
• W3045447168 hasAuthorship W3045447168A5044342382 @default.
• W3045447168 hasAuthorship W3045447168A5052001303 @default.
• W3045447168 hasAuthorship W3045447168A5058321251 @default.
• W3045447168 hasAuthorship W3045447168A5064872583 @default.
• W3045447168 hasAuthorship W3045447168A5066924600 @default.
• W3045447168 hasAuthorship W3045447168A5069065380 @default.
• W3045447168 hasAuthorship W3045447168A5073056054 @default.
• W3045447168 hasAuthorship W3045447168A5074112363 @default.
• W3045447168 hasAuthorship W3045447168A5076725199 @default.
• W3045447168 hasAuthorship W3045447168A5085351803 @default.
• W3045447168 hasAuthorship W3045447168A5086023651 @default.
• W3045447168 hasBestOaLocation W30454471681 @default.
• W3045447168 hasConcept C126322002 @default.
• W3045447168 hasConcept C143998085 @default.
• W3045447168 hasConcept C17923572 @default.
• W3045447168 hasConcept C207103383 @default.
• W3045447168 hasConcept C2778019345 @default.
• W3045447168 hasConcept C2778695046 @default.
• W3045447168 hasConcept C44249647 @default.

• next